Norman Doidge, citing a study by Merzenich and colleagues, found that the brain allocates neurological resources to its most ...

These eras of brain architecture are marked by four major turning points, which occur around the ages of 9, 32, 66 and 83, ...

Dr. Jennifer Adams, whose daughter was diagnosed at 18 months with PH1, calls Oxlumo a "life-changing medication." As a result, her daughter's "quality of life has improved, hospital visits were ...

Nancy Major, from Fannett, Texas, first felt like something was wrong when she developed what appeared to be an abscess near the back of her wisdom tooth.

Patients with high-risk treatment-refractory mantle cell lymphoma (MCL) show significant survival benefits with treatment with mosunetuzumab combined with polatuzumab vedotin (mosun-pola), new ...

PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving ...

New research challenges the status quo that cancer treatments are responsible for accelerating the aging process, indicating that cancer itself also plays a role. A team of researchers from Moffitt ...

TAMPA, Fla. (Aug. 22, 2025) — A new study led by a team of researchers at Moffitt Cancer Center reveals that lymphoma can accelerate the biological aging of the immune system and other tissues, ...

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial We integrated data from five prospective studies of frontline ...

This marks the first provincial listing of Polivy as a first-line treatment for DLBCL in Canada, highlighting Roche's ongoing commitment to meeting the diverse needs of healthcare systems and patients ...